Clinical Trial Update: Bone Healing During Ninlaro Exposure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining bone healing during Ninlaro exposure in multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• NINLARO (ixazomib)

Snippet

Sponsor: Thomas Lund | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED